
ABBOTT LABORATORIES — Investor Relations & Filings
Abbott Laboratories is a global healthcare company that discovers, develops, manufactures, and sells a broad portfolio of life-changing technologies. The company's operations are focused on four core businesses: Medical Devices, Diagnostics, Nutrition, and Established Pharmaceuticals. The Medical Devices division offers solutions for cardiovascular health, diabetes care (including the FreeStyle Libre continuous glucose monitoring system), and neuromodulation. The Diagnostics segment provides a wide range of in vitro diagnostic systems and tests for hospitals, laboratories, and clinics. The Nutrition business develops and markets science-based nutritional products for people of all ages, with leading brands such as Similac, PediaSure, Ensure, and Glucerna. The Established Pharmaceuticals division provides a portfolio of branded generic medicines to consumers in emerging markets.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| S-8 - ABBOTT LABORATORIES (0000001800) (Filer) | 2026-04-24 | English | |
| 8-K - ABBOTT LABORATORIES (0000001800) (Filer) | 2026-04-17 | English | |
| 8-K - ABBOTT LABORATORIES (0000001800) (Filer) | 2026-04-16 | English | |
| SCHEDULE 13G/A - ABBOTT LABORATORIES (0000001800) (Subject) | 2026-03-26 | English | |
| 4 - ABBOTT LABORATORIES (0000001800) (Issuer) | 2026-03-25 | English | |
| 3 - ABBOTT LABORATORIES (0000001800) (Issuer) | 2026-03-25 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 36260641 | S-8 - ABBOTT LABORATORIES (0000001800) (Filer) | 2026-04-24 | English | ||
| 34661940 | 8-K - ABBOTT LABORATORIES (0000001800) (Filer) | 2026-04-17 | English | ||
| 34647007 | 8-K - ABBOTT LABORATORIES (0000001800) (Filer) | 2026-04-16 | English | ||
| 33051650 | SCHEDULE 13G/A - ABBOTT LABORATORIES (0000001800) (Subject) | 2026-03-26 | English | ||
| 33043414 | 4 - ABBOTT LABORATORIES (0000001800) (Issuer) | 2026-03-25 | English | ||
| 33043382 | 3 - ABBOTT LABORATORIES (0000001800) (Issuer) | 2026-03-25 | English | ||
| 33016698 | S-8 - ABBOTT LABORATORIES (0000001800) (Filer) | 2026-03-23 | English | ||
| 33013457 | 8-K - ABBOTT LABORATORIES (0000001800) (Filer) | 2026-03-23 | English | ||
| 32874359 | 4 Filing | 2026-03-04 | English | ||
| 32874360 | 4 Filing | 2026-03-04 | English | ||
| 32874361 | 4 Filing | 2026-03-04 | English | ||
| 32874362 | 4 Filing | 2026-03-04 | English | ||
| 32874363 | 4 Filing | 2026-03-04 | English | ||
| 32874364 | 4 Filing | 2026-03-04 | English | ||
| 32874365 | 4 Filing | 2026-03-04 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
ANIMALCARE GROUP PLC
Develops and commercializes veterinary pharmaceutical produ…
|
ANCR | GB | Manufacturing |
|
ANI PHARMACEUTICALS INC
Develops, manufactures, and markets branded, generic, and O…
|
ANIP | US | Manufacturing |
|
ANLON HEALTHCARE LIMITED
Researches and manufactures APIs, intermediates, and finish…
|
AHCL | IN | Manufacturing |
|
Annexin Pharmaceuticals AB
Clinical-stage biotech developing a cell-protecting biologi…
|
ANNX | SE | Manufacturing |
|
Annexon, Inc.
Clinical-stage biopharma developing complement medicines by…
|
ANNX | US | Manufacturing |
|
Antengene Corporation Limited
Global biopharma developing and commercializing novel oncol…
|
6996 | KY | Manufacturing |
|
ANTEROGEN CO., LTD.
Develops and commercializes cell therapies and orphan drugs…
|
065660 | KR | Manufacturing |
|
Antibiotice S.A.
Pharmaceutical firm manufacturing generic medicines, anti-i…
|
ATB | RO | Manufacturing |
|
Anuh Pharma Ltd.
Manufacturer of APIs and bulk drugs specializing in Macroli…
|
ANUHPHR | IN | Manufacturing |
|
Apellis Pharmaceuticals, Inc.
Biopharmaceutical company developing therapies by targeting…
|
APLS | US | Manufacturing |
ABBOTT LABORATORIES via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/29777/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=29777 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=29777 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=29777 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 29777}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for ABBOTT LABORATORIES (id: 29777)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.